These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3890921)

  • 21. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
    Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN
    Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts.
    Konstantinova NV; Duong DM; Remenyik E; Hazarika P; Chuang A; Duvic M
    J Invest Dermatol; 1996 Oct; 107(4):615-21. PubMed ID: 8823370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibronectin and alpha5 integrin regulate keratinocyte cell cycling. A mechanism for increased fibronectin potentiation of T cell lymphokine-driven keratinocyte hyperproliferation in psoriasis.
    Bata-Csorgo Z; Cooper KD; Ting KM; Voorhees JJ; Hammerberg C
    J Clin Invest; 1998 Apr; 101(7):1509-18. PubMed ID: 9525994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A monoclonal antibody labelling the keratinocyte membrane: a marker of epidermal differentiation.
    Viac J; Haftek M; Staquet MJ; Reano A; Brochier J; Thivolet J
    Acta Derm Venereol; 1985; 65(1):1-8. PubMed ID: 2578699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructural localization of calcium in psoriatic and normal human epidermis.
    Menon GK; Elias PM
    Arch Dermatol; 1991 Jan; 127(1):57-63. PubMed ID: 1986708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in involucrin immunolabeling within cornified cell envelopes in normal and psoriatic epidermis.
    Ishida-Yamamoto A; Iizuka H
    J Invest Dermatol; 1995 Mar; 104(3):391-5. PubMed ID: 7861008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dolichos biflorus agglutinin (DBA) reveals a similar basal cell differentiation in normal and psoriatic epidermis.
    Kariniemi AL; Virtanen I
    Histochemistry; 1989; 93(2):129-32. PubMed ID: 2482277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
    van Erp PE; Rijzewijk JJ; Boezeman JB; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof PC; Ramaekers FC; Bauer FW
    Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a psoriatic skin model produced with involved or uninvolved cells.
    Jean J; Leroy M; Duque-Fernandez A; Bernard G; Soucy J; Pouliot R
    J Tissue Eng Regen Med; 2015 Jul; 9(7):789-98. PubMed ID: 23281213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of syndecan-1 in psoriatic epidermis.
    Tomas D; Vucić M; Situm M; Kruslin B
    Arch Dermatol Res; 2008 Aug; 300(7):393-5. PubMed ID: 18386024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of prekeratin and keratin polypeptides in normal and psoriatic human epidermis.
    Bowden PE; Wood EJ; Cunliffe WJ
    Biochim Biophys Acta; 1983 Feb; 743(1):172-9. PubMed ID: 6186286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered binding of Ulex europaeus I lectin to psoriatic epidermis.
    Kariniemi AL; Holthöfer H; Miettinen A; Virtanen I
    Br J Dermatol; 1983 Nov; 109(5):523-9. PubMed ID: 6357263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.
    Abe J; Kondo S; Nishii Y; Kuroki T
    J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
    Hammerberg C; Arend WP; Fisher GJ; Chan LS; Berger AE; Haskill JS; Voorhees JJ; Cooper KD
    J Clin Invest; 1992 Aug; 90(2):571-83. PubMed ID: 1386612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoelectron microscopic analysis of cornified cell envelope formation in normal and psoriatic epidermis.
    Ishida-Yamamoto A; Eady RA; Watt FM; Roop DR; Hohl D; Iizuka H
    J Histochem Cytochem; 1996 Feb; 44(2):167-75. PubMed ID: 8609373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nature of cell kinetics in psoriatic epidermis.
    Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
    J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.
    de Mare S; Van Erp PE; van de Kerkhof PC
    J Invest Dermatol; 1989 Jan; 92(1):130-1. PubMed ID: 2462594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic distribution of staining by a monoclonal antibody (psi-3) in psoriasis and occurrence of psi-3 antigen in other cutaneous diseases.
    Strefling AM; Knapp AM; Mansbridge JN
    J Invest Dermatol; 1985 Feb; 84(2):100-4. PubMed ID: 2578527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation.
    Leigh IM; Pulford KA; Ramaekers FC; Lane EB
    Br J Dermatol; 1985 Jul; 113(1):53-64. PubMed ID: 2410005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.